Journal
The Journal of clinical investigation
Publication Date
10-3-2022
Volume
132
Issue
19
First Page
e159229
Document Type
Open Access Publication
DOI
10.1172/JCI159229
Rights and Permissions
Liu Z, Liao F, Zhu J, Zhou D, Heo GS, Leuhmann HP, Scozzi D, Parks A, Hachem R, Byers DE, Tague LK, Kulkarni HS, Cano M, Wong BW, Li W, Huang HJ, Krupnick AS, Kreisel D, Liu Y, Gelman AE. Reprogramming alveolar macrophage responses to TGF-β reveals CCR2+ monocyte activity that promotes bronchiolitis obliterans syndrome. J Clin Invest. 2022 Oct 3;132(19):e159229. doi: 10.1172/JCI159229. © 2022, Liu et al. This is an open access article published under the terms of the Creative Commons Attribution 4.0 International License.
Recommended Citation
Liu, Zhiyi; Liao, Fuyi; Zhu, Jihong; Zhou, Dequan; Heo, Gyu Seong; Leuhmann, Hannah P.; Scozzi, Davide; Parks, Antanisha; Hachem, Ramsey; Byers, Derek E.; Tague, Laneshia K.; Kulkarni, Hrishikesh S.; Cano, Marlene; Wong, Brian W.; Li, Wenjun; Kreisel, Daniel; Gelman, Andrew E; and et al., "Reprogramming alveolar macrophage responses to TGF-β reveals CCR2+ monocyte activity that promotes bronchiolitis obliterans syndrome." The Journal of clinical investigation. 132, 19. e159229 (2022).
https://digitalcommons.wustl.edu/oa_4/633
Supplemental video 1.mp4 (1453 kB)
Supplemental video 2.mp4 (19027 kB)